NCT06476197 2025-07-17
Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy
S-Alpha Therapeutics, Inc.
Phase NA Completed
S-Alpha Therapeutics, Inc.
Oncocross Co. Ltd.
Cannabics Pharmaceuticals Inc.
Helsinn Therapeutics (U.S.), Inc
Helsinn Therapeutics (U.S.), Inc